These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3916764)

  • 1. Natural cell-mediated resistance against Cryptococcus neoformans: a possible role for natural killer (NK) cells.
    Murphy JW
    Curr Top Med Mycol; 1985; 1():135-54. PubMed ID: 3916764
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural killer cells and Cryptococcus neoformans.
    Murphy JW
    Adv Exp Med Biol; 1993; 335():269-75. PubMed ID: 8237604
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells.
    Hidore MR; Murphy JW
    Infect Immun; 1986 Feb; 51(2):547-55. PubMed ID: 3510981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural cellular resistance of beige mice against Cryptococcus neoformans.
    Hidore MR; Murphy JW
    J Immunol; 1986 Dec; 137(11):3624-31. PubMed ID: 3537121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans.
    Nabavi N; Murphy JW
    Infect Immun; 1986 Feb; 51(2):556-62. PubMed ID: 3510982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of macrophages in immunity and pathogenesis of experimental cryptococcosis induced by the airborne route--Part II: Phagocytosis and intracellular fate of Cryptococcus neoformans.
    Karaoui RM; Hall NK; Larsh HW
    Mykosen; 1977 Nov; 20(11):409-12. PubMed ID: 339078
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated immunity in Cryptococcosis.
    Graybill JR; Alford RH
    Cell Immunol; 1974 Oct; 14(1):12-21. PubMed ID: 4619352
    [No Abstract]   [Full Text] [Related]  

  • 8. Human natural killer cells do not inhibit growth of Cryptococcus neoformans in the absence of antibody.
    Miller MF; Mitchell TG; Storkus WJ; Dawson JR
    Infect Immun; 1990 Mar; 58(3):639-45. PubMed ID: 2407651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro binding of natural killer cells to Cryptococcus neoformans targets.
    Nabavi N; Murphy JW
    Infect Immun; 1985 Oct; 50(1):50-7. PubMed ID: 3899938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization of mice with a mutant of Cryptococcus neoformans. Characterization of the mutant, actively acquired resistance to experimental cryptococcosis in mice.
    Reiss F; Alture-Werber E
    Dermatologica; 1976; 152(1):16-22. PubMed ID: 780165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity in cryptococcosis: an overview.
    Fromtling RA; Shadomy HJ
    Mycopathologia; 1982 Mar; 77(3):183-90. PubMed ID: 7040977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of murine natural killer cells by Cryptococcus neoformans.
    Bartizal KF; Salkowski CA; Balish E
    Prog Clin Biol Res; 1985; 181():333-6. PubMed ID: 3895239
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients.
    Kyei SK; Ogbomo H; Li S; Timm-McCann M; Xiang RF; Huston SM; Ganguly A; Colarusso P; Gill MJ; Mody CH
    mBio; 2016 Aug; 7(4):. PubMed ID: 27555306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans.
    Murphy JW; McDaniel DO
    J Immunol; 1982 Apr; 128(4):1577-83. PubMed ID: 6120974
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunogenic fractions of Cryptococcus neoformans.
    Graybill JR; Straus DC; Nealon TJ; Hague M; Paque RE
    Mycopathologia; 1982 Apr; 78(1):31-9. PubMed ID: 7048099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective cell-mediated immunity against Cryptococcus neoformans.
    Murphy JW
    Res Immunol; 1998; 149(4-5):373-86; discussion 519-22. PubMed ID: 9720955
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection.
    Schimpff SC; Bennett JE
    J Allergy Clin Immunol; 1975 Jun; 55(6):430-41. PubMed ID: 1094054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans.
    Diamond RD; Bennett JE
    J Infect Dis; 1973 Jun; 127(6):694-7. PubMed ID: 4575001
    [No Abstract]   [Full Text] [Related]  

  • 19. Cryptococcus neoformans-specific oligoclonal immunoglobulins in cerebrospinal fluid in cryptococcal meningitis.
    Porter KG; Sinnamon DG; Gillies RR
    Lancet; 1977 Jun; 1(8024):1262. PubMed ID: 68362
    [No Abstract]   [Full Text] [Related]  

  • 20. A monoclonal antibody to gamma interferon blocks augmentation of natural killer cell activity induced during systemic cryptococcosis.
    Salkowski CA; Balish E
    Infect Immun; 1991 Feb; 59(2):486-93. PubMed ID: 1898905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.